# The Comparative Study of Intra-articular Injection of Tocilizumab and Compound Betamethasone

> **NCT03215407** · PHASE4 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Rheumatoid Arthritis of Knee

## Interventions

- **DRUG:** Intra-articular Tocilizumab
- **DRUG:** Intra-articular Compound Betamethasone

## Key facts

- **NCT ID:** NCT03215407
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-01
- **Primary completion:** 2017-12-12
- **Final completion:** 2018-03-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03215407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03215407, "The Comparative Study of Intra-articular Injection of Tocilizumab and Compound Betamethasone". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03215407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*